Researcher interests: Molecular mechanisms of antibody formation. Differentiation and malignant transformation of B lymphocytes. Cancer - genomic instability and genomic alterations in precancerous lesions and/or cancer. Rare diseases - the pathophysiology and natural course of patients with primary antibody deficiencies (PAD).
FACULTY / SCHOOL: School of Medicine - IMRIC
Contact Business Development: Shani Bullock

Selected Publications

claudeagnes reynaud, jeanluc teillaud, Reuven Laskov, mariecaroline dieunosjean, sandrine moutel
1st french israeli international conference on b cells and therapeutic antibodies october 23 25 2011 jerusalem israel (2012)| mAbs| Read more
Reuven Laskov, reiiny hamo, Michael Steinitz, valentina yahud
preferential targeting of somatic hypermutation to hotspot motifs and hypermutable sites and generation of mutational clusters in the igvh alleles of a rheumatoid factor producing lymphoblastoid cell line (2011)| Molecular Immunology| Read more
ilan chezar, Reuven Laskov, liat lobellavi, Michael Steinitz
ongoing somatic hypermutation of the rearranged vh but not of the v lambda gene in ebv transformed rheumatoid factor producing lymphoblastoid cell line (2008)| Molecular Immunology| Read more
benjamin klein, hannah ben bassat, Reuven Laskov, nir berger
cytotoxicity of nf κb inhibitors bay 11 7085 and caffeic acid phenethyl ester to ramos and other human b lymphoma cell lines (2007)| Experimental Hematology| Read more
Reuven Laskov, sarah levynabot, Michael Steinitz, yaniv gil
somatic mutations and activation induced cytidine deaminase aid expression in established rheumatoid factor producing lymphoblastoid cell line (2007)| Molecular Immunology| Read more
Reuven Laskov, marshall horwitz, matthew scharff, nir berger
tumor necrosis factor α and cd40l modulate cell surface morphology and induce aggregation in ramos burkitt s lymphoma cells (2006)| Leukemia & Lymphoma| Read more
Reuven Laskov, marshall horwitz, nir berger
differential effects of tumor necrosis factor α and cd40l on nf κb inhibitory proteins iκbα β and e and on the induction of the jun amino terminal kinase pathway in ramos burkitt lymphoma cells (2005)| European Cytokine Network| Read more
joseph riss, Reuven Laskov
expression of novel alternatively spliced isoforms of the oct 1 transcription factor (1999)| Biochimica et Biophysica Acta| Read more
chana gabay, Reuven Laskov, Malka Hochberg
somatic mutations in the ig variable region genes and expression of novel cmu germline transcripts in a b lymphoma cell line farage not producing ig polypeptide chains (1998)| Leukemia & Lymphoma| Read more

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: